BrIDGs Projects

BrIDGs projects benefit from certain critical resources needed for the development of new therapeutic agents. Successful applicants receive access to NIH contractors who conduct pre-clinical synthesis, formulation, pharmacokinetic and toxicology services at no cost to the investigator. Click on the links below to view active and completed BrIDGs projects:

Related Links

Contact

New BrIDGs Projects

On Oct. 29, 2014, NCATS announced two new pre-clinical drug development projects aimed at finding treatments for diabetic keratopathy — a condition that often leads to blindness — and severe heart attacks. Read the announcement.